ResearcherHenan University of Science and TechnologyNo recent work listed

Lulin Zhang

Provisional: name at one institution (moderate confidence, 0.60), identity_conf@1As of 8 November 2026

Known by name at one institution; no external author ID yet. Sources: OpenAlex.

Their work

Papers: 2 (first author 1, last author 0)
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 3

Papers, trials and grants by year

2017: 1 paper · 2018: 1 paper

Papers 2

Micro-RNA-21 Regulates Cancer-Associated Fibroblast-Mediated Drug Resistance in Pancreatic Cancer. Co-author DOI 10.3727/096504017x14934840662335 ↗
Pleiotrophin and N-syndecan promote perineural invasion and tumor progression in an orthotopic mouse model of pancreatic cancer. First author DOI 10.3748/wjg.v23.i21.3907 ↗

Closest collaborators

The 3 strongest of 3 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Jun Yao · 2 shared papers, 2017–2018 · strength 0.21
- Paper Micro-RNA-21 Regulates Cancer-Associated Fibroblast-Mediated Drug Resistance in Pancreatic Cancer. DOI 10.3727/096504017x14934840662335 ↗
- Paper Pleiotrophin and N-syndecan promote perineural invasion and tumor progression in an orthotopic mouse model of pancreati… DOI 10.3748/wjg.v23.i21.3907 ↗
Ce Zhang · 1 shared paper, 2018 · strength 0.12
- Paper Micro-RNA-21 Regulates Cancer-Associated Fibroblast-Mediated Drug Resistance in Pancreatic Cancer. DOI 10.3727/096504017x14934840662335 ↗
Shegan Gao · 1 shared paper, 2017 · strength 0.09
- Paper Pleiotrophin and N-syndecan promote perineural invasion and tumor progression in an orthotopic mouse model of pancreati… DOI 10.3748/wjg.v23.i21.3907 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.